(Total Views: 579)
Posted On: 01/10/2021 9:02:55 PM
Post# of 145880
Havasu,
I don't believe that receptor occupancy is part of the CD12 trial any more than viremia.
Any "peaking behind the curtain" would, I believe, have to more indirect through normal blood chemistries and cell counts that are run in the course of the clinical care for these patients.
I don't believe that receptor occupancy is part of the CD12 trial any more than viremia.
Any "peaking behind the curtain" would, I believe, have to more indirect through normal blood chemistries and cell counts that are run in the course of the clinical care for these patients.
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)